0001209191-21-038457.txt : 20210604
0001209191-21-038457.hdr.sgml : 20210604
20210604200948
ACCESSION NUMBER: 0001209191-21-038457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210603
FILED AS OF DATE: 20210604
DATE AS OF CHANGE: 20210604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reasons Bryan M.
CENTRAL INDEX KEY: 0001553489
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 21997966
MAIL ADDRESS:
STREET 1: C/O IMPAX LABORATORIES, INC.
STREET 2: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 640 LEE ROAD
STREET 2: SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 484-324-7933
MAIL ADDRESS:
STREET 1: 640 LEE ROAD
STREET 2: SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-03
0
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001553489
Reasons Bryan M.
C/O ACLARIS THERAPEUTICS, INC.
640 LEE ROAD, SUITE 200
WAYNE
PA
19087
1
0
0
0
Stock Option (Right to Buy)
21.90
2021-06-03
4
A
0
12250
0.00
A
2031-06-02
Common Stock
12250
12250
D
Restricted Stock Units
2021-06-03
4
A
0
3356
0.00
A
Common Stock
3356
3356
D
This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy.
The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date.
Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date.
/s/ Mark Ballantyne, Attorney-in-Fact
2021-06-04